DENISE BYRD: Open Payments
NPI 1801850391 · NEW ROCHELLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 36 payments from 16 companies in 2025. Trend: 2023 $565 · 2024 $851 · 2025 $1,171
Food & beverage: $1,093Education: $78
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $161 |
| GlaxoSmithKline, LLC. | 2 | $137 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Madrigal Pharmaceuticals | 3 | $83 |
| Janssen Biotech, Inc. | 1 | $78 |
| Lilly USA, LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $41 |
| SOBI, INC | 1 | $27 |
Products named: ENTYVIO, EPKINLY, NERLYNX, JEMPERLI, OPDIVO, REZDIFFRA, ERLEADA, OMVOH.
Industry payments across NY — which companies pay providers there.
